Fluorodeoxyglycose (FDG) PET as an outcome measure for metastatic prostate cancer Meeting Abstract


Authors: Morris, M. J.; Fox, J. J.; Dennis, E. R.; Tse, K.; Flatts, E.; Heller, G.; Jia, X.; Schoder, H.; Larson, S. M.; Scher, H. I.
Abstract Title: Fluorodeoxyglycose (FDG) PET as an outcome measure for metastatic prostate cancer
Meeting Title: 46th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 28
Issue: 15 Suppl.
Meeting Dates: 2010 Jun 4-8
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2010-05-20
Start Page: 376s
Language: English
ACCESSION: WOS:000208852004008
DOI: 10.1200/jco.2010.28.15_suppl.4638
PROVIDER: wos
Notes: Meeting Abstract: 4638 -- S -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Josef J Fox
    71 Fox
  2. Glenn Heller
    399 Heller
  3. Michael Morris
    577 Morris
  4. Xiaoyu Jia
    46 Jia
  5. Heiko Schoder
    543 Schoder
  6. Steven M Larson
    958 Larson
  7. Howard Scher
    1130 Scher
  8. Elizabeth Rose Dennis
    5 Dennis
  9. Kin   Tse
    6 Tse
  10. Ernest Flatts
    2 Flatts